Pro-Dex Inc

NASDAQ PDEX

Data sourced from iex and EODHD
Download Data

Pro-Dex Inc Enterprise Value to Sales (EV/S) on June 03, 2024: 1.47

Pro-Dex Inc Enterprise Value to Sales (EV/S) is 1.47 on June 03, 2024, a -7.78% change year over year. The EV/Sales ratio, also known as the revenue multiple, compares a company's enterprise value to its revenue. It provides insight into the company's valuation relative to its sales and is commonly used in valuation analysis. A lower ratio suggests a potentially more favorable valuation.
  • Pro-Dex Inc 52-week high Enterprise Value to Sales (EV/S) is 1.94 on January 30, 2024, which is 32.12% above the current Enterprise Value to Sales (EV/S).
  • Pro-Dex Inc 52-week low Enterprise Value to Sales (EV/S) is 1.34 on October 13, 2023, which is -9.00% below the current Enterprise Value to Sales (EV/S).
  • Pro-Dex Inc average Enterprise Value to Sales (EV/S) for the last 52 weeks is 1.52.
NASDAQ: PDEX

Pro-Dex Inc

CEO Mr. Richard Lee Van Kirk Jr.
IPO Date Aug. 18, 1995
Location United States
Headquarters 2361 McGaw Avenue, Irvine, CA, United States, 92614
Employees 145
Sector Healthcare
Industry Medical instruments & supplies
Description

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

StockViz Staff

September 19, 2024

Any question? Send us an email